[CNS-active pyrans: amine- and aryl- substituted dioxabicyclooctanes]

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Organic Synthesis

Background:

• 6,8-dioxabicyclooctanes are scaffolds with potential biological activity.
• Central nervous system (CNS) activity is influenced by molecular structure and stereochemistry.
• The N-methyl-D-aspartate (NMDA) receptor complex, particularly its phencyclidine (PCP) binding site, is a target for CNS-active compounds.

Purpose of the Study:

• To synthesize novel 6,8-dioxabicyclooctanes with varying amine-phenyl distances.
• To investigate the CNS activities of these synthesized compounds in mice.
• To evaluate the binding affinity of these compounds to the PCP-binding site of the NMDA receptor complex.

Main Methods:

• Synthesis of aminophenyl-substituted 6,8-dioxabicyclooctanes.
• In vivo behavioral studies in mice to assess CNS effects.
• In vitro receptor binding assays targeting the PCP-binding site of the NMDA receptor.

Main Results:

• Synthesized compounds 10 and 11 demonstrated distinct CNS activities.
• The intensity and profile of CNS effects were dependent on the amine substituent and product stereochemistry.
• Receptor binding studies provided insights into the interaction with the NMDA receptor complex.

Conclusions:

• The structural features of 6,8-dioxabicyclooctanes, including amine type, stereochemistry, and amine-phenyl distance, significantly modulate their CNS activity.
• These findings highlight the potential of 6,8-dioxabicyclooctanes as a chemical class for developing novel CNS-acting agents targeting the NMDA receptor.